{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Infant%2C+Newborn%2C+Disease&page=3", "query": { "condition": "Infant, Newborn, Disease", "page": 3 }, "page_size": 10 }, "pagination": { "page": 3, "page_size": 10, "total_count": 1945, "total_pages": 195, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Infant%2C+Newborn%2C+Disease&page=4&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Infant%2C+Newborn%2C+Disease&page=2&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-09T09:26:59.763Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00599053", "title": "Early Versus Expectant Treatment of Ureaplasma Infection in Very Low Birth Weight Neonates", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Bacteria Infection", "Respiratory Tract Infections" ], "interventions": [ { "name": "Azithromycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "3 Days", "sex": "ALL", "summary": "1 Day to 3 Days" }, "enrollment_count": 7, "start_date": "2007-05", "completion_date": "2009-08", "has_results": true, "last_update_posted_date": "2017-05-17", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00599053" }, { "nct_id": "NCT00732537", "title": "Inhaled Nitric Oxide by Oxygen Hood in Neonates", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Respiratory Failure", "Infant", "Persistent Fetal Circulation" ], "interventions": [ { "name": "inhaled Nitric Oxide", "type": "DRUG" }, { "name": "Oxygen (>90% by hood) - standard therapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Alabama at Birmingham", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Hour", "maximum_age": "1 Week", "sex": "ALL", "summary": "1 Hour to 1 Week" }, "enrollment_count": 8, "start_date": "1999-03", "completion_date": "2005-06", "has_results": false, "last_update_posted_date": "2008-08-12", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 1, "location_summary": "Birmingham, Alabama", "locations": [ { "city": "Birmingham", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT00732537" }, { "nct_id": "NCT03311503", "title": "Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Severe Combined Immunodeficiency, X Linked", "Gene Therapy" ], "interventions": [ { "name": "autologous CD34+ cell transduced with G2SCID vector", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "David Williams", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "0 Years", "maximum_age": "5 Years", "sex": "MALE", "summary": "0 Years to 5 Years · Male only" }, "enrollment_count": 12, "start_date": "2018-02-26", "completion_date": "2028-01-01", "has_results": false, "last_update_posted_date": "2025-12-11", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 4, "location_summary": "Los Angeles, California • Atlanta, Georgia • Boston, Massachusetts + 1 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cincinnati", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT03311503" }, { "nct_id": "NCT06539169", "title": "FLOWER: Following Longitudinal Outcomes With Epidemiology for Rare Diseases", "overall_status": "UNKNOWN", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Alpha-Thalassemia", "Beta-Thalassemia", "Amyloidosis", "Amyotrophic Lateral Sclerosis", "Creutzfeld-Jakob Disease", "Cystic Fibrosis", "Duchenne Muscular Dystrophy", "Early-Onset Alzheimer Disease", "Ehlers-Danlos Syndrome", "Huntington Disease", "Gaucher Disease", "GM1 Gangliosidosis", "Myasthenia Gravis", "Pompe Disease", "Sickle Cell Disease", "Transthyretin Amyloid Cardiomyopathy", "Rare Diseases" ], "interventions": [], "intervention_types": [], "sponsor": "xCures", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 1000, "start_date": "2024-06-10", "completion_date": "2026-06-10", "has_results": false, "last_update_posted_date": "2024-11-14", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 1, "location_summary": "Los Altos, California", "locations": [ { "city": "Los Altos", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06539169" }, { "nct_id": "NCT00005660", "title": "The Evaluation of Oral Acitretin in the Treatment of Psoriasis, Cutaneous Disorders of Keratinization, Multiple Basal Cell Carcinomas and Other Retinoid Responsive Diseases", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Basal Cell Carcinoma", "Keratosis Palmaris et Plantaris", "Psoriasis" ], "interventions": [], "intervention_types": [], "sponsor": "National Cancer Institute (NCI)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 130, "start_date": "1977-10", "completion_date": "2001-11", "has_results": false, "last_update_posted_date": "2008-03-04", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 1, "location_summary": "Bethesda, Maryland", "locations": [ { "city": "Bethesda", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00005660" }, { "nct_id": "NCT01483079", "title": "Post-Discharge Growth of Infants Who Received Donor Human Milk Products in the Neonatal Intensive Care Unit (NICU)", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Prematurity" ], "interventions": [], "intervention_types": [], "sponsor": "Baylor College of Medicine", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 51, "start_date": "2011-12", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2026-01-29", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 1, "location_summary": "Houston, Texas", "locations": [ { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01483079" }, { "nct_id": "NCT02496780", "title": "The Impact of Insulin Therapy on Protein Turnover in Pre-Diabetic Cystic Fibrosis Patients", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Cystic Fibrosis" ], "interventions": [ { "name": "novolog insulin", "type": "DRUG" }, { "name": "levemir insulin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "10 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "10 Years to 25 Years" }, "enrollment_count": 65, "start_date": "2015-08", "completion_date": "2022-07", "has_results": true, "last_update_posted_date": "2025-03-17", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 2, "location_summary": "Minneapolis, Minnesota • Saint Paul, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Saint Paul", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT02496780" }, { "nct_id": "NCT04294368", "title": "Targeted Fortification of Donor Breast Milk in Preterm Infants", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Prematurity; Extreme", "Failure to Thrive in Newborn", "Growth Retardation", "Growth Failure", "Infant Nutrition Disorders" ], "interventions": [ { "name": "Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid", "type": "DIETARY_SUPPLEMENT" }, { "name": "Similac Liquid Protein Fortifier", "type": "DIETARY_SUPPLEMENT" }, { "name": "Nestle Microlipid", "type": "DIETARY_SUPPLEMENT" }, { "name": "Medica Nutrition SolCarb", "type": "DIETARY_SUPPLEMENT" }, { "name": "Similac Human Milk Fortifier Extensively Hydrolyzed Protein Concentrated Liquid (Targeted Fortification)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Similac Liquid Protein Fortifier (Targeted Fortification)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Nestle Microlipid (Targeted Fortification)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Medica Nutrition SolCarb (Targeted Fortification)", "type": "DIETARY_SUPPLEMENT" }, { "name": "Analysis with Miris (AB) Human Milk Analyzer", "type": "OTHER" } ], "intervention_types": [ "DIETARY_SUPPLEMENT", "OTHER" ], "sponsor": "Columbia University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Day", "maximum_age": "21 Days", "sex": "ALL", "summary": "1 Day to 21 Days" }, "enrollment_count": 50, "start_date": "2020-03-09", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-04-07", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT04294368" }, { "nct_id": "NCT01852370", "title": "Sequential Cadaveric Lung and Bone Marrow Transplant for Immune Deficiency Diseases", "overall_status": "ENROLLING_BY_INVITATION", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Severe Combined Immunodeficiency (SCID)", "Immunodeficiency With Predominant T-cell Defect, Unspecified", "Severe Chronic Neutropenia", "Chronic Granulomatous Disease (CGD)", "Hyper IgE Syndromes", "Hyper IgM Deficiencies", "Wiskott-Aldrich Syndrome", "Mendelian Susceptibility to Mycobacterial Disease", "Common Variable Immune Deficiency (CVID)" ], "interventions": [ { "name": "CD3/CD19 negative allogeneic hematopoietic stem cells", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Paul Szabolcs", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "45 Years", "sex": "ALL", "summary": "5 Years to 45 Years" }, "enrollment_count": 16, "start_date": "2013-06-20", "completion_date": "2027-11", "has_results": false, "last_update_posted_date": "2025-12-15", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01852370" }, { "nct_id": "NCT04821453", "title": "NAVA vs. CMV Crossover in Severe BPD", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Bronchopulmonary Dysplasia", "Neurally Adjusted Ventilatory Assist", "Mechanical Ventilation" ], "interventions": [ { "name": "NAVA", "type": "DEVICE" }, { "name": "CMV", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": "24 Months", "sex": "ALL", "summary": "Up to 24 Months" }, "enrollment_count": 12, "start_date": "2021-09-13", "completion_date": "2025-02-28", "has_results": true, "last_update_posted_date": "2026-05-20", "last_synced_at": "2026-10-09T09:26:59.763Z", "location_count": 2, "location_summary": "Philadelphia, Pennsylvania • Providence, Rhode Island", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Providence", "state": "Rhode Island" } ], "official_url": "https://clinicaltrials.gov/study/NCT04821453" } ] }